domingo, 20 de setembro de 2026
PesquisarExplore
Via News Knowledge File

NVIDIA Corporation

organization80% conf.·synced Sep 20, 2026

Technology company specializing in semiconductors and AI chips, IPO in 1999, Taiwan semiconductor dependency

60
sourced metrics
5477
relationships
20
stated objectives
8
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Stock Price
218.36USD
Sep 10, 2026reference only
Price 52 Week Low
165.17USD
Sep 10, 2026reference only
Stock Return Ytd
15.6%
Sep 10, 2026reference only
Market Cap
5284312000000USD
Sep 10, 2026reference only
Price 52 Week High
235.74USD
Sep 10, 2026reference only
Shares Outstanding
24200000000.0shares
May 15, 2026reference only
Gross Profit
61157000000.0USD
Apr 26, 2026reference only
Stockholders Equity
195474000000.0USD
Apr 26, 2026reference only
Net Income
58321000000.0USD
Apr 26, 2026reference only
Total Liabilities
64000000000.0USD
Apr 26, 2026reference only
Operating Income
53536000000.0USD
Apr 26, 2026reference only
Rd Expense
6321000000.0USD
Apr 26, 2026reference only
Total Assets
259474000000.0USD
Apr 26, 2026reference only
Cost Of Revenue
20458000000.0USD
Apr 26, 2026reference only
Operating Cash Flow
50344000000.0USD
Apr 26, 2026reference only
Revenue
81615000000.0USD
Apr 26, 2026reference only
Cash
13237000000.0USD
Apr 26, 2026reference only
Eps
2.39USD_per_share
Apr 26, 2026reference only

Stated objectives

Regain billions of dollars in lost business through China market

source
target: billions stated

Share 15% or more of revenue from China sales with US government

source
target: 15 stated

Commission over 1 million square feet for manufacturing Blackwell chips in Arizona and AI supercomputers in Texas

source
target: 1 million square feet stated

Ramp up mass production of AI supercomputers in Texas by September 2026

source
by 2026-09-01 00:00:00stated

Q4 FY2026 revenue target

source
target: $65.0 billion, plus or minus 2% by 2026-01-25 00:00:00stated

Q4 FY2026 GAAP gross margin target

source
target: 74.8%, plus or minus 50 basis points by 2026-01-25 00:00:00stated

Q4 FY2026 non-GAAP gross margin target

source
target: 75.0%, plus or minus 50 basis points by 2026-01-25 00:00:00stated

Start shipping H200 chips to China

source
by 2026-02-01 00:00:00stated

Deliver up to 10x reduction in inference token cost compared to Blackwell platform

source
target: 10x stated

Reduce number of GPUs needed to train MoE models by 4x compared to Blackwell

source
target: 4x reduction stated

Relationship graph · 5477 connections

Developed by
1328
Supplies to
909
Competes with
729
Covered by
505
Customer of
424
Employs
320
Invested in
224
Partners with
176

Via News coverage

This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
Sinalizamos conflitos abertamente ›
Verificado recentemente
Verificado com a fonte original
4,982
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,982 factos verificados com a fonte5,299 documentos-fonte arquivados
Consulte estes dados → isubstrate.com